MULTIPLE SYSTEM ATROPHY
Clinical trials for MULTIPLE SYSTEM ATROPHY explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SYSTEM ATROPHY trials appear
Sign up with your email to follow new studies for MULTIPLE SYSTEM ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental protein therapy targets rare brain disease
Disease control Not yet recruitingThis early-phase trial tests a drug called ALT001, a nerve repair protein, in 60 people with multiple system atrophy (MSA), a rare and progressive brain disorder. The study is open-label, meaning everyone knows they are getting the drug, and it focuses on safety and whether the d…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: EARLY_PHASE1 • Sponsor: yilong Wang • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New brain scan tracer could spot Alzheimer's and Parkinson's earlier
Diagnosis Not yet recruitingThis early-phase trial will test a new radioactive tracer called 18F-FCOB04 in 40 people with neurodegenerative diseases like Alzheimer's or Parkinson's. The tracer targets a brain protein called MAO-B and is used with PET scans to see if it can help diagnose these conditions. Th…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: EARLY_PHASE1 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
New smart system aims to catch dangerous blood pressure drops earlier
Diagnosis Not yet recruitingThis study will test a new intelligent diagnostic system for orthostatic hypotension (a sudden drop in blood pressure when standing up). The system continuously monitors blood pressure, brain blood flow, and heart signals to classify the condition more precisely. Researchers plan…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Sponsor: Xuanwu Hospital, Beijing • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Could a common stroke drug help people with a rare brain disease?
Symptom relief Not yet recruitingThis study tests whether butylphthalide, a drug used for stroke, can improve symptoms of Multiple System Atrophy (MSA), a rare and serious brain disorder. About 150 adults with MSA will take either the drug or a placebo three times a day for six months. Researchers will track sym…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: PHASE2, PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Study to reveal emotional impact of lewy body biomarker disclosure
Knowledge-focused Not yet recruitingThis study from Stanford University will look at how people react when they learn their Lewy Body Disease biomarker test results. Researchers will interview and survey 40 participants, both with and without symptoms, to measure distress and other responses over time. The goal is …
Matched conditions: MULTIPLE SYSTEM ATROPHY
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to spot Parkinson's early with simple blood, urine, and stool tests
Knowledge-focused Not yet recruitingThis observational study will enroll 200 people—100 with Parkinson's disease, 50 with related conditions, and 50 healthy controls—to find molecular markers in blood, urine, and stool that can distinguish Parkinson's from atypical parkinsonism. Participants provide samples and und…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Sponsor: International Institute of Molecular and Cell Biology in Warsaw • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC